Research notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

A milestone filled year

TPG Telecom Ltd
3:27pm
August 28, 2025
TPG’s 1H25 result was broadly in line with recent expectations. The result is complex due to the divestment but underlying trends are as announced a few weeks ago. Costs were tightly controlled and mobile subscriber growth is starting to gain some momentum. We have updated our forecasts, including removing the now divested EGW business and including the series of capital considerations announced earlier this month. We retain our HOLD recommendation while our target price increases to $5.50.

Snore no more

SomnoMed
3:27pm
August 28, 2025
SomnoMed delivered a clean FY25 result, with revenue of A$111.5m and underlying EBITDA of A$9.2m, above guidance and in-line with our forecasts. With manufacturing constraints resolved and operating cash flow turning positive, the business appears well positioned to scale efficiently. We see the long-term angle here remains prepping SOM up as either a moderately profitable standalone business, or potential M&A acquirer / target as its scale builds and cost synergies align. This result was a step in the right direction. Our target price moderates to A$0.99 (from A$1.00) and we retain our SPECULATIVE BUY recommendation.

Hard to fault but overvalued

Wesfarmers
3:27pm
August 28, 2025
WES’s FY25 result was largely in line with expectations. Earnings for most divisions were in line with our forecasts. Health was a standout with a stronger-than-expected jump in earnings. The announcement of a $1.50ps capital return (comprising a fully-franked special dividend of $0.40ps and capital component of $1.10ps) was another highlight. Management said the retail divisions traded well in the first 8 weeks of FY26. Encouragingly, they have seen a modest improvement in consumer demand on the back of a moderation in inflation and the recent interest rate cuts. We make minimal changes to earnings forecasts but lift our target price to $83.20 (from $75.80). This reflects another solid result, demonstrating strong execution by management and early signs of improvement in consumer sentiment, which should support a more positive outlook for trading conditions. With a forecast 12-month TSR of -6%, we maintain our TRIM rating. While we continue to view WES as a core long-term portfolio holding with a diversified group of well-known retail and industrial brands, a healthy balance sheet, and an experienced leadership team with a strong track record of growth, trading on 36.9x FY26F PE we see the stock as overvalued in the short term.

Healthy earnings, but guidance reset weighs

South32
3:27pm
August 28, 2025
FY25 result steady, but FY26 guidance reset at Mozal (C&M risk) and Cannington (lower throughput, higher costs) clouds near-term earnings. Hermosa build year pushes group capex to US$1.4bn in FY26, keeping FCF tight despite trimmed sustaining spend. Sierra Gorda copper volumes up 20%, but limited near-term catalysts and consensus downgrades pressure weigh on sentiment. Dividend of US 2.6cps; US$144m remains in buyback program. Maintain BUY with reduced target price of A$3.55 (was A$4.10).

More Supply Agreements needed

Micro-X
3:27pm
August 28, 2025
MX1 posted its FY25 result, which was behind our forecasts. Lower product sales was the area we underestimated. However, the recent signing of a Supply Agreement with a major healthcare provider should see sales of the Rover Plus increase in FY26 and FY27. We expect similar agreements are likely to follow. The focus on medical imaging appears to be paying off. We have made no changes to our forecasts and our target price remains unchanged at A$0.17. We maintain our SPECULATIVE BUY recommendation.

Brighter future ahead

Beacon Lighting
3:27pm
August 28, 2025
BLX reported NPAT decline of 0.7% on an underlying basis, which was ~7% lower than expected driven by lower LFL sales and higher operating costs. Encouragingly, sales momentum improved through the year and accelerated in the 4Q, and has been maintained into FY26. Trade sales continues to grow, with top line sales up >20%. Trade now represents 40% of relevant sales and the company remains on track for 50/50 split trade and retail by FY28. We have lowered our NPAT forecasts by 9%/7% respectively in FY26/27, pushing out the strong earnings recovery and operating leverage into FY27. We expect significant leverage in this business when consumer sentiment and housing cycle turns. We have upgraded to an ACCUMULATE, with a $3.80 TP (was $3.55).

Stabilising operations appear priced in

Mineral Resources
3:27pm
August 28, 2025
MIN delivered a solid FY25 result with EBITDA ahead of forecasts and underlying NPAT well ahead of forecasts on lower D&A and net interest. FY26 guidance was in line, although MorgansF/consensus were at the top-end of guidance. MIN confirmed Onslow has been running at a 35mtpa run rate for the last 4 weeks, and the haul road repair will complete in mid-September. We move to a TRIM rating with a A$34ps target price (previously A$31ps) reflecting our view that MIN’s stabilising operations are already priced in following its strong share price run.

Putting the trade back in the shade

Clinuvel Pharmaceuticals
3:27pm
August 28, 2025
FY25 result itself was marginally below expectations with higher-than-expected expenses delivered a miss to profit lines and a continued failure to change the narrative around capital management and disclosures which continues to keep a lid on the upside. Seasonal 2H strength carried the year along with margins still flattered by low materials costs which we expect will normalise in FY26. Cash balance remains an eyesore, now up to A$224m (~35% of market cap), and buy-back capacity effectively untouched and no uplift in dividend. We called CUV out as a potential beat candidate in our pre-reporting season report given the seasonally strong trading period, but happy to close out following a strong SP appreciation in the leadup. Our target price reduces to A$14 (from A$15) and we downgrade to a HOLD recommendation.

Backlog support underpins favorable outlook

Worley
3:27pm
August 28, 2025
WOR delivered a solid FY25 result, which came broadly in line with MorgF and consensus, with Underlying EBITA of $823m (+10% YoY), driven by Aggregate revenue growth 4%, Underlying EBITA margin (ex-procurement) improved 130bps. WOR’s outlook for FY26 remains positive with the group flagging that they are not seeing any material project cancellations, across end markets, providing confidence in moderate revenue growth & stable EBITA margins in FY26. We trim our Underlying EBITA forecast by -2%, in FY26/27F, to align more closely with the Groups outlook. This sees us retain our BUY rating and price target of $16.80/sh).

Shaping up for sales growth in FY26

ImpediMed
3:27pm
August 28, 2025
IPD posted its FY25 result reporting a net loss higher than our forecast. Importantly, the operating cash outflow was better than our expectations. Our focus is the growth of the installed base in the US which now seems to be gaining momentum with 4Q25 delivering a record 44 SOZO units. We expect subsequent quarters to continue to build on this. We have made modest downgrades to our short-term forecasts, which sees our valuation move to A$0.14 (from A$0.15). We maintain a SPECULATIVE BUY recommendation on IPD.

News & insights

Uncover insights from Jackson Hole: Jay Powell’s rate cut hints, Fed’s soft landing concerns, and dire demographic trends. Analysis by Morgans’ Chief Economist.


There is more to what happened at Jackson Hole than just the speech by Jay Powell.

In my talk last week ,I said that our model of the Fed funds rate stood at 3.65%. This is actually 70 basis points lower than the actual  level of 4.35%.

I also said that the Fed was successfully achieving a "soft landing" with employment growing at 1%. This was below the median level of employment growth  since 2004 of 1.6%.

Still , as I listened to Jay Powell Speak , I noted a sense of concern in his voice when he said that "The July employment report released earlier this month slowed to an average pace of only 35,000 average per month over the past three months, down from 168,000 per month during 2024. This slowdown is much larger than assessed just a month ago."

My interpretation of this is that Chair Powell may be concerned that the "soft landing " achieved by the Fed may be in danger of turning into a "hard landing". This suggested a rate cut of 25 basis points by the Fed at the next meeting on 17-18 September.

This would leave the Fed Funds rate at 4.1%. This would mean that the Fed Funds rate would still be 45 basis points higher than our model estimate of 3.65%. Hence the Fed Funds rate would remain "modestly restrictive."

Dire Demography?

Jackson Hole was actually a Fed Strategy meeting with many speakers in addition to Jay Powell.

Two speakers who followed on the  afternoon of his speech were Claudia Goldin, Professor at Harvard

and Chad Janis of Stanford Graduate Business School. They each gave foreboding presentations on the demography of developed economies.

Claudia Goldin spoke on "The Downside of Fertility".  She noted that birth rates in the Developed World are now generally  below replacement level. The Total Fertility rate is below 2 in France , the US and the UK.

It is dangerously low below 1.5 in Italy and Spain and below 1 in Korea. She observes that the age of first marriage of couples  in the US is now 7 years later than it was in the 1960's. This reduces  their child bearing years.

This paper was then followed by a discussion of it by Chad Janis of Stanford Graduate Business School. He noted that there is a profound difference between a future with a replacement rate of 2.2 kids per family , which he called  the "Expanding Cosmos"  with

•   Growing population leading to a growing number of researchers, leading to rising living standards  and Exponential growth in both living standards and population AND a replacement level of 1.9 kids per family which leads to  

•   Negative population growth , which he called "an Empty Planet " and the end of humanity

 as numbers of researchers declines and economic growth ceases.

Of course this seems all  very serious indeed .  Perhaps what this really means ,is that  if  we want to save the world , we should just relax and start having a lot more fun!!

Read more
Michael Knox, Chief Economist explains how the RBA sets interest rates to achieve its 2.5% inflation target, predicting a cash rate reduction to 3.35% by November when inflation is expected to reach 2.5%, based on a historical average real rate of 0.85%.

Today, we’re diving into how the Reserve Bank of Australia (RBA) sets interest rates as it nears its target of 2.5% inflation, and what happens when that target is reached. Back in 1898, Swedish economist Knut Wicksell  published *Money, Interest and Commodity Prices*, introducing the concept of the natural rate of interest. This is the real interest rate that maintains price stability. Unlike Wicksell’s time, modern central banks, including the RBA, focus on stabilising the rate of inflation rather than the price level itself.

In Australia, the RBA aims to keep inflation at 2.5%. To achieve this, it sets a real interest rate, known as the neutral rate, which can only be determined in practice by observing what rate stabilises inflation at 2.5%. Looking at data from January 2000, we see significant fluctuations in Australia’s real cash rate, but over the long term, the average real rate has been 0.85%. This suggests that the RBA can maintain its 2.5% inflation target with an average real cash rate of 0.85%. This is a valuable insight as the RBA approaches this target.

Australian Real Cash Rate -July 2025

As inflation nears 2.5%, we can estimate that the cash rate will settle at 2.5% (the inflation target) plus the long-term real rate of 0.85%, resulting in a cash rate of 3.35%. At the RBA meeting on Tuesday, 12 August, when the trimmed mean inflation rate for June had already  dropped to 2.7%, the RBA reduced the real cash rate to 0.9%, resulting in a cash rate of 3.6%.

We anticipate that when the trimmed mean inflation for September falls to 2.5%, as expected, the cash rate will adjust to 2.5% plus the long-term real rate of 0.85%, bringing it to 3.35%. The September quarter trimmed mean will be published at the end of October, just before the RBA’s November meeting. We expect the RBA to hold the cash rate steady at its September meeting, but when it meets in November, with the trimmed mean likely at 2.5%, the cash rate is projected to fall to 3.35%.

Australian Real Cash Rate - August 2025
Read more
Michael Knox, Chief Economist looks at what might have happened in January 2026 if the cuts in corporate tax rates in Trumps first term were not renewed and extended in the One Big Beautiful Bill

In recent weeks, a number of media commentators have criticized Donald Trump's " One big Beautiful Bill " on the basis of a statement by the Congressional Budget Office that under existing legislation the bill adds $US 3.4 trillion to the US Budget deficit. They tend not to mention that this is because the existing law assumes that all the tax cuts made in 2017 by the first Trump Administration expire at the end of this year.

Let’s us look at what might have happened in January 2026 if the cuts in US corporate tax rates in Trumps first term were not renewed and extended in the One Big Beautiful Bill.

Back in 2016 before the first Trump administration came to office in his first term, the US corporate tax rate was then 35%. In 2017 the Tax Cut and Jobs Act reduced the corporate tax rate to 21%. Because this bill was passed as a "Reconciliation Bill “, This meant it required only a simple majority of Senate votes to pass. This tax rate of 21% was due to expire in January 2026.

The One Big Beautiful Bill has made the expiring tax cuts permanent; this bill was signed into law on 4 July 2025. Now of course the same legislation also made a large number of individual tax cuts in the original 2017 bill permanent.

What would have happened if the bill had not passed. Let us construct what economists call a "Counterfactual"

Let’s just restrict ourselves to the case of what have happened in 2026 if the US corporate tax had risen to the prior rate of 35%.

This is an increase in the corporate tax rate of 14%. This increase would generate a sudden fall in US corporate after-tax earnings in January 2026 of 14%. What effect would that have on the level of the S&P 500?

The Price /Earnings Ratio of the S&P500 in July 2025 was 26.1.

Still the ten-year average Price/ Earnings Ratio for the S&P500 is only 18.99. Let’s say 19 times.

Should earnings per share have suddenly fallen by 14%, then the S&P 500 might have fallen by 14% multiplied by the short-term Price/ Earnings ratio.

This means a likely fall in the S&P500 of 37%.

As the market recovered to long term Price Earnings ratio of 19 this fall might then have ben be reduced to 27%.

Put simply, had the One Big, beautiful Bill not been passed, then in 2026 the US stock market might suddenly have fallen by 37% before then recovering to a fall of 27% .

The devastating effect on the US and indeed World economy might plausibly have caused a major recession.

On 9 June Kevin Hassert the Director of the National Economic Council said in a CBS interview with Margaret Brennan that if the bill did not pass US GDP would fall by 4% and 6-7 million Americans would lose their jobs.

The Passage of the One Big Beautiful Bill on 4 July thus avoided One Big Ugly Disaster.

Read more